Radiotherapy and regional hyperthermia in prostate cancer
Prof. Dr. András Szász, founder of oncothermia: "Surgery in prostate cancer often leads to complications and side effects. Complementary medicine aims at a gentle, concomitant treatment of oncological therapies. The goal is to increase the effect of chemotherapy or radiotherapy co-medically, to reduce its dosage, but also to attack cancer cells directly by heat and to increase the subjective well-being of patients. "He refers to data from the statistics institute Eurostat , Prostate cancer is the most common type of cancer, with approximately 26 percent of men. The German Cancer Society registers approximately 63,400 new cases nationwide each year. The risk of developing prostate cancer is 13; the risk of death at 3 percent. This makes prostate cancer the most common cancer, but not the leading cause of death. The probability of being alive 5 years after diagnosis is the second highest among all cancers in Germany at 93 percent, according to the Cancer Society.
In about half of the surgical treatments for prostate cancer, the organ is removed, says Prof. Szász. "Many patients suffer from complications, side effects and sequelae such as impotence, urinary incontinence. Complementary medicine seeks to support conventional procedures and reduce side effects. We want to activate the self-healing powers, strengthen the immune system but also increase the quality of life after conventional surgery. Prostate cancer in particular puts a strain on the patient, both physically and mentally. Complementary medicine respects this when it networks conventional therapies with others such as regional heat therapy. "(Pm)